Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: For human use
Package code: 1709793
Name of medicinal product: SOMAVERT
Active substances:
Pegvisomant
Estonian, English, Latin
ATC code: H01AX01
Dosage form: powder and solvent for solution for injection
Route of administration: subcutaneous use
Strengh: 30mg
Amount in package: 30TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information: lahusti 1 ml
Indication: Treatment of adult patients with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not normalize IGF-I concentrations or was not tolerated.
Safety features: Yes
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Labelling:  
Last imported to Estonia: January 19, 2023
Marketing authorization holder: Pfizer Europe MA EEIG 
Marketing authorization number: EU/1/02/240 
Marketing authorization issued on: July 17, 2015 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Centralised 
Reference price:   
Under reference price:   
Reference price of daily dose:   
Entry/Changing date: September 13, 2018
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere